MedPath

亿腾医药(苏州)有限公司

Ownership
-
Established
2019-02-26
Employees
-
Market Cap
-
Website
www.ceclorpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Fluticasone Propionate Nebuliser Suspension

Product Name
丙酸氟替卡松雾化吸入用混悬液
Approval Number
国药准字H20247005
Approval Date
Jan 8, 2024
NMPA

Cefaclor Capsules

Product Name
希刻劳
Approval Number
国药准字H10983030
Approval Date
May 22, 2020
NMPA

Cefaclor Sustained Release Tablets(Ⅱ)

Product Name
希刻劳
Approval Number
国药准字H20020571
Approval Date
May 22, 2020
NMPA

Cefaclor for Suspension

Product Name
希刻劳
Approval Number
国药准字H10983028
Approval Date
May 22, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.